2022 - Research.com Best Scientist Award
2010 - Ho-Am Prize in Medicine, Samsung Foundation
1953 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
William C. Hahn mostly deals with Cancer research, Genetics, Cell biology, Cancer cell and Telomerase. His research in Cancer research intersects with topics in Cell, Carcinogenesis, Cancer, Oncogene and Immunology. As part of his studies on Cell biology, William C. Hahn frequently links adjacent subjects like Transcription factor.
His studies deal with areas such as Epithelial–mesenchymal transition and KRAS as well as Cancer cell. In his study, which falls under the umbrella issue of Telomerase, Cytotoxic T cell is strongly linked to Antigen. His work carried out in the field of Telomerase reverse transcriptase brings together such families of science as Telomere, Cell culture, Cell division and Molecular biology.
William C. Hahn mainly focuses on Cancer research, Cancer, Genetics, Cell biology and Gene. His Cancer research research is multidisciplinary, incorporating perspectives in Carcinogenesis, Cancer cell, Oncogene, Kinase and Prostate cancer. His Cancer study integrates concerns from other disciplines, such as Malignant transformation, Bioinformatics, Functional genomics, Genomics and Computational biology.
His work is connected to Allele and Mutation, as a part of Genetics. His Cell biology research incorporates themes from Telomere, Molecular biology, Transcription factor and Telomerase. His work in Telomere tackles topics such as Telomerase reverse transcriptase which are related to areas like Cell culture.
His primary scientific interests are in Cancer research, Cancer, Computational biology, Gene and CRISPR. The study incorporates disciplines such as Cell culture, Pancreatic cancer, Cell growth, RNA interference and Prostate cancer in addition to Cancer research. His Cancer research is multidisciplinary, incorporating elements of Mutation, Genome editing and DNA methylation.
His Computational biology study combines topics in areas such as Cell, Phenotype, Genome, Genome scale and Cancer cell lines. His Gene study is concerned with the larger field of Genetics. His Cancer cell study integrates concerns from other disciplines, such as KRAS, Somatic cell, Glutathione and Cell biology.
William C. Hahn spends much of his time researching Cancer research, Gene, Cancer, Mutation and Cell biology. His study in Cancer research is interdisciplinary in nature, drawing from both Cell, Cancer cell, Mdm2, Prostate cancer and Kinase. To a larger extent, he studies Genetics with the aim of understanding Gene.
His Cancer research incorporates themes from Interferon, Regulation of gene expression and Adenosine deaminase. His research investigates the link between Mutation and topics such as Mutant that cross with problems in Oncogene, Function, KRAS and Effector. He interconnects Oxidative stress, Cell culture, ADAR and Transcription factor, Chromatin remodeling in the investigation of issues within Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Creation of human tumour cells with defined genetic elements
William C. Hahn;William C. Hahn;Christopher M. Counter;Ante S. Lundberg;Ante S. Lundberg;Roderick L. Beijersbergen.
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari;Tim Fenton;Robert M. Bachoo;Akitake Mukasa.
Genes & Development (2007)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore;Ghayas C. Issa;Madeleine E. Lemieux;Peter B. Rahl.
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Jason Moffat;Dorre A. Grueneberg;Xiaoping Yang;So Young Kim;So Young Kim.
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie;Pablo Tamayo;Jesse S. Boehm;So Young Kim.
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Andrei V. Krivtsov;David Twomey;David Twomey;Zhaohui Feng;Matthew C. Stubbs.
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen;Jesse S. Boehm;So Young Kim;Sapana R. Thomas;Sapana R. Thomas.
Inhibition of telomerase limits the growth of human cancer cells
William C. Hahn;Sheila A. Stewart;Mary W. Brooks;Shoshana G. York.
Nature Medicine (1999)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis.
Modelling the molecular circuitry of cancer.
William C Hahn;William C Hahn;Robert A Weinberg.
Nature Reviews Cancer (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: